Clinical Trial Update: Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on oral pooled fecal microbiotherapy to prevent complications after allogeneic hematopoietic cell transplantation. Recruitment is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• fecal microbiota transplantation (oral pooled) (fecal microbiota transplantation)

Snippet

Sponsor: MaaT Pharma | Conditions: Transplant Complication | Phase 2 | Status: RECRUITING